National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 70201 [2019-27507]
Download as PDF
<![CDATA[
70201
Federal Register / Vol. 84, No. 245 / Friday, December 20, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Short-Term Research Experience for Underrepresented Persons (STEP–UP) Application.
STEP–UP Student Feedback Form .....................
Diversity Summer Research Training Program
(DSRTP) Feedback Form.
Network of Minority Health Research Investigators (NMRI) Enrollment Form.
NMRI Evaluation Form .........................................
NMRI Survey Form ...............................................
NMRI Mentor-Mentee Agreement Form ...............
NIH/National Medical Association (NMA) Academic Career Fellow Travel Awards Application.
NIH/NMA Feedback Form ....................................
NIH/National Hispanic Medical Association
(NHMA) Academic Career Fellow Travel
Awards Application.
NIH/NHMA Feedback Form ..................................
Total ...............................................................
Dated: December 12, 2019.
Starsky Cheng,
NIDDK Project Clearance Liaison, Office of
Management and Policy Analysis, National
Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2019–27514 Filed 12–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ZAI1 FDS M M1, January
30–31, 2020, Targeted Prevention for
Tickborne Diseases (R01—Clinical Trials Not
Allowed).
Date: January 30–31, 2020.
VerDate Sep<11>2014
18:30 Dec 19, 2019
Number of
respondents
Type of respondent
Jkt 250001
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hours
Individuals/Households
2,000
1
45/60
1,500
Individuals/Households
Individuals/Households
200
14
1
1
15/60
30/60
50
7
Private Sector ...............
200
1
15/60
50
Private
Private
Private
Private
...............
...............
...............
...............
120
800
100
200
1
1
1
1
30/60
30/60
30/60
20/60
60
400
50
67
Private Sector ...............
Private Sector ...............
40
200
1
1
30/60
20/60
20
67
Private Sector ...............
40
1
30/60
20
.......................................
........................
3,914
........................
2,291
Sector
Sector
Sector
Sector
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Frank S. De Silva, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room #3E72A, National Institutes of Health,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, MSC 9823,
Rockville, MD 20892–9823, (240) 669–5023,
fdesilva@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 16, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27507 Filed 12–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Drug Abuse.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: January 30, 2020.
Closed: 9:00 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC),
Conference Rooms C&D, 6001 Executive
Boulevard, Rockville, MD 20852.
Open: 10:30 a.m. to 4:30 p.m.
Agenda: This portion of the meeting will
be open to the public for announcements and
reports of administrative, legislative, and
program developments in the drug abuse
field.
Place: National Institutes of Health,
Neuroscience Center Building (NSC),
Conference Rooms C&D, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Susan R.B. Weiss, Ph.D.,
Director, Division of Extramural Research,
Office of the Director, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, NSC, Room 5274, MSC 9591,
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 84, Number 245 (Friday, December 20, 2019)]
[Notices]
[Page 70201]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27507]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; ZAI1 FDS M M1, January 30-31, 2020,
Targeted Prevention for Tickborne Diseases (R01--Clinical Trials Not
Allowed).
Date: January 30-31, 2020.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Frank S. De Silva, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room #3E72A, National Institutes of Health, National
Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, MSC
9823, Rockville, MD 20892-9823, (240) 669-5023,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 16, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-27507 Filed 12-19-19; 8:45 am]
BILLING CODE 4140-01-P
